MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Vera Therapeutics, Inc. Class A Common Stock

VERA

#1508
Vera Therapeutics, Inc. Class A Common Stock
40.7900
-1.57%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
40.7900
40.7900
Intervallo Annuale
23.0500
56.0400
Variazione giornaliera
-1.57%
Variazione Mensile
-12.75%
Variazione di 6 mesi
+37.16%
Variazione Annuale
+37.16%
Chiusura Precedente
41.4400
Open
40.7900
Bid
Ask
Low
40.7900
High
40.7900
Volume
185
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. VERA
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 20212022202320242025 TTM

Notizie

Seeking Alpha Seeking Alpha
VERA
2026.02.20
Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)
Investing Investing
LLY VERA
2026.02.02
VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg
Investing Investing
VERA
2026.01.28
Vera Therapeutics promuove Matt Skelton a direttore commerciale
Investing Investing
VERA
2026.01.28
Vera Therapeutics promotes Matt Skelton to chief commercial officer
Investing Investing
VERA
2026.01.27
JPMorgan conferma il rating Overweight per le azioni di Vera Therapeutics
Investing Investing
VERA
2026.01.27
JPMorgan reiterates Overweight rating on Vera Therapeutics stock
Investing Investing
VERA
2026.01.16
Cantor Fitzgerald conferma rating Overweight su azioni Vera Therapeutics
Investing Investing
VERA
2026.01.16
Cantor Fitzgerald reiterates Overweight rating on Vera Therapeutics stock
Zacks Zacks
VERA
2026.01.14
Wall Street Analysts See a 53.05% Upside in Vera Therapeutics (VERA): Can the Stock Really Move This High?
Seeking Alpha Seeking Alpha
VERA
2026.01.14
Vera Therapeutics, Inc. (VERA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Investing Investing
VERA
2026.01.07
Il titolo di Vera Therapeutics sale dopo l’accettazione della BLA per atacicept
Investing Investing
VERA
2026.01.07
Vera Therapeutics stock rises after FDA accepts atacicept BLA with Priority Review

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd